Rosnilimab

• Target :

  PD-1/PD-L1

• Related Pathways :

  Cell Cycle/Checkpoint|||Immunology/Inflammation|||Apoptosis

• Purity :

  0.989

• Bioactivity :

  Rosnilimab (ANB030) is a programmed cell death protein 1 (PD-1) agonist that can inhibit antigen-driven T cell proliferation, reduce the secretion of pro-inflammatory cytokines, and deplete CD4 and CD8 T cell populations characterized by high PD-1 expression, thereby enabling its use in the research of various inflammatory diseases such as colitis and rheumatoid arthritis.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  2412764-40-8